Aberrant Upregulation of 14-3-3σ and EZH2 Expression Serves as an Inferior Prognostic Biomarker for Hepatocellular Carcinoma

• Yi Zhang,

  Affiliation Department of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, P.R. China

  ⨯
• Yang Li,

  Affiliation Department of Hepatobiliary Surgery, Affiliated Hospital of Guilin Medical University, Guilin, P.R. China

  ⨯
• Changwei Lin,

  Affiliation Department of Gastrointestinal Surgery, Third Xiangya Hospital, Central South University, Changsha, P.R. China

  ⨯
• Jie Ding,

  Affiliation Department of Gastrointestinal Surgery, Guizhou Provincial People's Hospital, Guiyang, P.R. China

  ⨯
• Guoqing Liao ,

  * E-mail: liaoguoqing@medmail.com.cn (GL); dytangbo@163.com (BT)

  Affiliation Department of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, P.R. China

  ⨯
• Bo Tang

  * E-mail: liaoguoqing@medmail.com.cn (GL); dytangbo@163.com (BT)

  Affiliation Department of Hepatobiliary Surgery, Affiliated Hospital of Guilin Medical University, Guilin, P.R. China

  ⨯